September 26, 2026 · O&G open · DOI: 10.1097/og9.0000000000000188

Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy.

Listen to this summary

This case report describes two pregnant patients on buprenorphine/naloxone whose urine drug screens unexpectedly presumed positive for opiates, prompting the question of whether this reflected return to opioid use. Confirmatory testing revealed only low-level noroxymorphone (46 and 79 ng/mL) with no detectable parent opioids, indicating it arose from naloxone metabolism rather than illicit or prescribed opioid use. The authors conclude that clinicians should recognize naloxone-derived noroxymorphone to avoid misclassifying patients and causing distress, including potential child welfare consequences.

Marcela C Smid, Jasmin E Charles, Gwendolyn A McMillin

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play